Interferon Alfa
Showing 1 - 25 of 2,867
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)
Not yet recruiting
- Essential Thrombocythemia
- Bomedemstat
- +4 more
- (no location specified)
Oct 6, 2023
Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)
Completed
- Kidney Cancer
- recombinant interferon alfa
- tretinoin liposome
-
New York, New York
- +1 more
Mar 17, 2022
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b
Recruiting
- Hepatocellular Carcinoma
- Anti-PD-1/PD-L1
- PEG-Interferon Alfa
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Mar 28, 2022
Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)
Active, not recruiting
- Malignant Melanoma
- Peginterferon alfa-2b
- +2 more
-
San Diego, California
- +2 more
Apr 1, 2022
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)
Completed
- Juvenile Pilocytic Astrocytomas
- Optic Pathway Gliomas
- Pegylated interferon alpha-2b
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jan 18, 2022
Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)
Recruiting
- Bowel Preparation
- OSS
- +2 more
-
Nanjing, Jiangsu, ChinaA single-center, single-blind, randomized controlled clinical st
Oct 20, 2023
HIV Trial in United States (Interferon alfa-2a, Zidovudine, Zalcitabine)
Completed
- HIV Infections
- Interferon alfa-2a
- +2 more
-
Birmingham, Alabama
- +3 more
Oct 27, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 28, 2021
HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)
Completed
- HIV Infections
- CD4-IgG
- +4 more
-
Bethesda, MarylandNatl Inst of Allergy & Infect Dis / Cln Ctr
Oct 26, 2021
Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
Miami, FloridaUniv of Miami School of Medicine
Oct 27, 2021
Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)
Completed
- Advanced Renal Cell Carcinoma
- Pazopanib + interferon alpha 2A
-
Hospitalet de Llobregat, Barcelona, Spain
- +12 more
Mar 9, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022
Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C
- Peginterferon alfa-2a
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Center
Aug 26, 2021
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 7, 2022